TEZSPIRE is an add-on maintenance treatment for people aged 12 and older with severe asthma. TEZSPIRE is not a rescue medication.
Administration and Dosage:
• Administer by subcutaneous injection.
• Recommended dosage is 210 mg administered once every 4 weeks.
Common Side Effects:
The most common side effects of TEZSPIRE include: Sore throat, joint and back pain. These are not all the possible side effects.
Please see full Prescribing Information including Patient Information.
Ready to Schedule an Appointment?
Please CLICK HERE to get started.
TEZSPIRE is a thymic stromal lymphopoietin (TSLP) blocker, human monoclonal antibody (IgG2λ), indicated for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma.